Artemis Medicare Services Limited (NSE: ARTEMISMED) announced its financial results for Q1 FY27, marking a strong start to the fiscal year with significant growth across key financial metrics. The consolidated revenue from operations for the quarter ended June 30, 2026, registered a 12.7% year-over-year increase to Rs 28,732 Lacs, up from Rs 25,496 Lacs in the same period last year.

Consolidated Performance Highlights

The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) surged by 27.9% to Rs 6,182 Lacs, compared to Rs 4,832 Lacs in Q1 FY26. Profit after tax (PAT) also saw a substantial increase, rising 48.3% to Rs 3,144 Lacs against Rs 2,120 Lacs in the previous year. Diluted earnings per share (EPS) grew by 46.7% to Rs 1.98, up from Rs 1.35.

Gurgaon Hospital Performance

Artemis Hospital Gurgaon, the flagship facility, performed exceptionally well with revenue from operations up by 15.4% to Rs 27,849 Lacs. The EBITDA for the hospital increased by 24.4% to Rs 6,163 Lacs, and the profit after tax grew by 32.7% to Rs 3,306 Lacs. Bed capacity utilisation improved to 65.7% from 61.2%, and the average revenue per occupied bed (ARPOB) rose to Rs 85,690 from Rs 79,752.

Commenting on the performance, Mr. Onkar Kanwar, Chairman, Artemis Medicare Services Ltd, said, “We have commenced FY27 on a strong note, delivering another quarter of consistent growth across our financial and operating metrics. The robust performance reflects the resilience of our business model, disciplined execution, and our continued commitment to delivering high-quality healthcare services.”

Dr. Devlina Chakravarty, Managing Director, added, “The first quarter of FY27 reflects the continued strength of our operational strategy, with healthy revenue growth, improved margins, and strong profitability. Our focus on operational excellence, clinical quality, and disciplined cost management has enabled us to enhance financial performance while ensuring patient care remains at the heart of everything we do.”

Artemis Medicare Services Limited is well positioned to create enduring value for its patients, stakeholders, and shareholders, backed by improving profitability, a healthy balance sheet, and a clear strategic roadmap.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Artemis Medicare Services Limited

Artemis Medicare Services Limited. Here’s a quick read on where the business and the stock stand today.

Artemis gains 19.8% over three months and trades near its 52-week highs. Thin margins at 9.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue grows at only 0.0% and profits at 0.0% CAGR. In effect, the business treads water. Buyers show up with 2.5x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. Price climbs recently despite 0.0% revenue growth and a PEG of 99.00. Consequently, either institutions position ahead of improvement or the move fades when earnings disappoint. Treat this as a trading signal, not an investment thesis. Check Fundamentals of Artemis Medicare Services Limited.

Artemis Medicare Services Limited announced its financial results for Q4 FY26, showcasing a robust performance. The consolidated revenue from operations increased by 16.4% year-on-year to Rs 27,923 Lacs. The EBITDA grew by 23.1% to Rs 5,938 Lacs, while the net profit surged by 32.1% to Rs 3,028 Lacs.

Artemis Hospital Gurgaon Performance

The flagship facility in Gurgaon demonstrated significant growth. The average revenue per occupied bed (ARPOB) rose to Rs 84,571 from Rs 78,835. Revenue from operations increased by 18.8% to Rs 26,746 Lacs. EBITDA grew by 20.6% to Rs 5,804 Lacs, and PAT increased by 19.8% to Rs 3,136 Lacs.

Consolidated Performance

Consolidated revenue from operations for Q4 FY26-27 grew by 16.4% to Rs 27,923 Lacs compared to the same period last year. The EBITDA increased by 23.1% to Rs 5,938 Lacs, and the PAT rose by 32.1% to Rs 3,028 Lacs. The company’s overseas patient revenue increased by 13.5% to Rs 8,226 Lacs, contributing significantly to the net revenue.

Mr. Onkar Kanwar, Chairman, Artemis Medicare Services Ltd, commented on the performance, stating, ‘We are pleased with our performance in the final quarter of FY26, which reflects steady progress and consistent execution across our operations.’ Dr. Devlina Chakravarty, Managing Director, emphasized operational discipline and efficiency initiatives that supported the improved profitability.

Artemis Medicare Services Limited remains committed to strengthening its clinical capabilities, enhancing operational efficiencies, and pursuing calibrated expansion to build a resilient and future-ready healthcare platform.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Artemis Medicare Services Limited

Artemis Medicare Services Limited. Here’s a quick read on where the business and the stock stand today.

Artemis rises 22.2% over three months, with buying pressure holding steady. Thin margins at 9.3% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue grows at only 0.0% and profits at 0.0% CAGR. In effect, the business treads water. RSI hits 74, a level that signals the stock runs hot. Notably, buyers drove volume on 19 recent sessions — though at these levels, some profit-taking is normal. The stock rises 22.2% in three months. Yet revenue grows at only 0.0% and the PEG stands at 99.00. Either the market prices in a turnaround that has not shown up yet, or this is momentum without substance. Check the next two earnings prints before drawing conclusions. Check Fundamentals of Artemis Medicare Services Limited.